Prudential Financial Inc Surface Oncology, Inc. Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.61 - $1.03 $16,958 - $28,634	27,800 Added 248.21%	39,000 $27,000
Q4 2022 Feb 14, 2023	BUY	$0.62 - $1.21 $6,944 - $13,552	11,200 New	11,200 $0
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $695,991 - $1.54 Million	-490,135 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.65 - $5.08 $607,115 - $1.16 Million	229,100 Added 87.77%	490,135 $1.44 Million
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $173,993 - $290,601	36,785 Added 16.4%	261,035 $1.25 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $636,795 - $984,811	123,410 Added 122.38%	224,250 $1.7 Million
Q2 2021 Aug 16, 2021	BUY	$6.45 - $9.09 $650,418 - $916,635	100,840 New	100,840 $752,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.